Navigation Links
Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Date:10/9/2009

NATICK, Mass., Oct. 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2009 on Tuesday, October 20, at 8:00 a.m. ET.

The call will be hosted by Ray Elliott, President and Chief Executive Officer, and Sam Leno, Executive Vice President and Chief Financial Officer.

The live webcast and archived replay of this call will be available at www.bostonscientific.com in the Investor Relations section. The webcast is also being distributed over Thomson Financial's Investor Distribution Network via two locations: www.earnings.com, which is accessible to the public, and www.streetevents.com, a password-protected event management site.

To ensure a timely connection to the live webcast it is recommended that users register at least 15 minutes before the webcast begins. A replay of the webcast will begin at approximately 11:00 a.m. ET on October 20 and will be available for one year.

A press release will be issued after the close of the market on Monday, October 19.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com. 

    CONTACT:  Paul Donovan
              508-650-8541
              Media Relations
              Boston Scientific Corporation

              Larry Neumann
              508-650-8696
              Investor Relations
              Boston Scientific Corporation
'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Switzerland , February 9 /PRNewswire/ ... group of companies with,a focus on the ... medical,needs, today announced the signature of an ... manufacture and commercialisation of Debio 025,(alisporivir), a ... anti-hepatitis C virus (HCV) effect. The product ...
(Date:2/8/2010)... ST. LOUIS , Feb. 8 ... Allied Healthcare Products (Nasdaq: AHPI ) narrowly back ... 2010. ,, Sales for the quarter ended December ... $12.5 million during the same quarter last ... quarter. However, Allied,s costs of sales were reduced even ...
(Date:2/8/2010)... BRUNSWICK, N.J. , Feb. 8 ... that the company will release financial results for the ... the market on Thursday, February 25, 2010 . ... Gionco, Group Vice President and Chief Financial Officer, will ... 10:00 a.m. Eastern Time on February 26, ...
Breaking Medicine Technology:Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 2Clinical Logistics Enters Partnership with Gentris Corporation 4974 1Clinical Logistics Enters Partnership with Gentris Corporation 4974 2Biologists discover death stench is a universal ancient warning signal 9892 1Biologists discover death stench is a universal ancient warning signal 9892 2Project Lifesaver International Receives Federal Assistance for the Missing Alzheimers Patient Assistance Program 56958 1Project Lifesaver International Receives Federal Assistance for the Missing Alzheimers Patient Assistance Program 56958 2Project Lifesaver International Receives Federal Assistance for the Missing Alzheimers Patient Assistance Program 56958 3
... Dec. 6 Some 5,000 COPD patients will ... Deficiency (Alpha-1) in,a study marking a major cooperative ... for Respiratory Care (AARC)., The principal investigator ... of Pulmonary Medicine, National Jewish Medical and Research ...
... Inc. (Nasdaq: RIGL ) today announced that its ... Phase 1 clinical trial of an,inhaled formulation of Rigel,s ... allergic asthma. R343 is the third product candidate,in Rigel,s ... 2005 collaboration agreement, Rigel,will receive a $5 million milestone ...
Other Medicine Technology:Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
(Date:2/9/2010)... The following statement is attributable ... President, American Medical Association: ,, (Logo: ... Association is pleased to support First Lady ... Move Campaign. As the nation,s largest physician ... obesity and are committed to reenergizing our ...
(Date:2/9/2010)... Cancer Institute and the Sanford-Burnham Medical Research Institute ... wholly owned member of the Roche group, and ... manufacture, develop and market human monoclonal antibodies to ... These viruses include the strains for the current ... have a non-exclusive right to manufacture, develop and ...
(Date:2/9/2010)... their skins, but some restaurants and population groups also ... eating these animals can have side effects that call ... Parasites, bacteria and viruses, and to a lesser extent ... eating reptile meat can cause several problems to health. ... the International Journal of Food Microbiology , which ...
(Date:2/9/2010)... Rhonda Roby , PhD, ... University of North Texas Center for Human Identification ... in recently identifying three murder victims of the Chilean ... The Chilean government contacted Roby in 2006 ... team of the victims, identification program for Patio 29. ...
(Date:2/9/2010)... Dr. Franois Robert, a researcher at the Institut de ... team of Dr. Daniel Durocher (Samuel Lunenfeld Research Institute ... mapped all the fragile sites of a living organism, ... used by the researchers can be applied to humans. ... scientific journal Nature Structural and Molecular Biology . ...
Breaking Medicine News(10 mins):Health News:Study carried out into biological risks of eating reptiles 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3
... of all family caregivers of Alzheimer,s disease patients succumb ... one and become hospital patients themselves, according to an ... of the Journal of General Internal Medicine . ... Medicine, the Regenstrief Institute and the Indiana University Center ...
... Key Factors Related to Online Detailing,s Significant ... /PRNewswire-FirstCall/ - According to an analysis of,physician prescribing ... leading provider of physician access through its innovative ... "highest value" to a,major pharmaceutical company participated in ...
... of Regence workers participate in annual giving effort, ... campaign record and bucked a national trend that threatens,charitable ... outlook -- or perhaps because of it --,Regence employees ... the company,s 50 percent match, local communities will,receive a ...
... Scientists from Maastricht University have developed a method to look ... has spoken to him or her and what was said. ... researchers mapped the brain activity associated with the recognition of ... "Who" is Saying "What"? Brain-Based Decoding of Human Voice and ...
... But study questions if MRIs, CT scans are always worth ... use of MRI and CT scanners in the United States ... resulted in better health care or fewer deaths, according to ... The researchers analyzed Medicare claims data and found that the ...
... wellness services to internal medicine, combining nutrition, education, fitness planning, ... ... one location., PHILADELPHIA, Nov. 10 Doctor Leslie Saltzman ... Wellness Center, the first primary medical care outpatient center,offering integrated ...
Other Medicine News:Health News:Caring for the caregiver: Redefining the definition of patient 2Health News:New Survey Indicates "Highest-Value" Physicians Most Likely to Participate in Aptilon's Live Video Detailing Service 2Health News:New Survey Indicates "Highest-Value" Physicians Most Likely to Participate in Aptilon's Live Video Detailing Service 3Health News:Trend-Breaking Employee Campaign Raises Nearly $2.5 Million 2Health News:Maastricht University researchers produce 'neural fingerprint' of speech recognition 2Health News:Use of Imaging Technology Skyrockets 2Health News:Use of Imaging Technology Skyrockets 3Health News:Rittenhouse Women's Wellness Center: Internal Medicine plus Nutrition, Fitness, Emotional Well-Being and Skin Care 2
... Neonates to adults, the entire series of ... knowledge of the needs of care providers ... in the accuracy. You can see it ... in the performance, year after year. Every ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
Medicine Products: